{"id":3462,"date":"2017-11-15T17:02:34","date_gmt":"2017-11-15T22:02:34","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3462"},"modified":"2017-11-15T17:02:43","modified_gmt":"2017-11-15T22:02:43","slug":"secondaries-announced-11-15-2017","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-11-15-2017\/","title":{"rendered":"Secondaries Announced 11.15.2017"},"content":{"rendered":"<h4><strong>IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n<p>If having\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/ipo-boutique-announces-new-secondary-alert-service\/#sthash.HnSepMmy.dpbs\" target=\"_blank\"><strong>real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,<a style=\"border-bottom-width: 1px; border-bottom-style: solid; border-bottom-color: #333333; color: #333333; text-decoration: none;\" href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">\u00a0inquire about a subscription today!<\/a><\/p>\n<p>Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n<p>Company: <strong>Veritone, Inc.<\/strong><br \/>\nSymbol: VERI<br \/>\nPrice: Last Trade $28.98<br \/>\nTrade Date: Week of 11\/20<br \/>\nShares: 0.8 million<br \/>\nUnderwriter(s) : Roth Capital, Craig Hallum<br \/>\nDescription: We have developed a proprietary artificial intelligence, or AI, platform that unlocks the power of cognitive computing to transform audio, video and other unstructured data and analyze it in conjunction with structured data in a seamless, orchestrated and automated manner to generate actionable intelligence.<br \/>\nRating =<strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Mirati Therapeutics, Inc.<br \/>\nSymbol: MRTX<br \/>\nPrice: Last Trade $14.05<br \/>\nTrade Date: 11\/16<br \/>\nShares: 5.4 million ($75 million cash raise)<br \/>\nRe-Offer Range: <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><br \/>\nUnderwriter(s) : Cowen, Barclays<br \/>\nDescription: Mirati Therapeutics is a clinical-stage biotechnology company focused on developing a pipeline of targeted oncology products intended to treat specific genetic and epigenetic drivers of cancer.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Norwegian Cruise Line &#8211; Block<br \/>\nSymbol: NCLH<br \/>\nPrice: Last Trade $55.07<br \/>\nTrade Date: 11\/16<br \/>\nShares: 10 million<br \/>\nRe-Offer Range: <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><br \/>\nUnderwriter(s) : Morgan Stanley<br \/>\nDescription: They are a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: Talend SA<br \/>\nSymbol: TLND<br \/>\nPrice: Last Trade $41.80<br \/>\nTrade Date: 11\/16<br \/>\nShares: 2.75 million<br \/>\nRe-Offer Range:<strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><br \/>\nUnderwriter(s) : Citigroup, Barclays<br \/>\nDescription: They are a next generation leader in cloud and big data integration solutions that helps companies become data driven by making data more accessible, improving its quality and quickly moving data where it\u2019s needed for real-time decision making.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n<p>Company: <strong>AxoGen, Inc.<\/strong><br \/>\nSymbol: AXGN<br \/>\nPrice: Last Trade $24.90<br \/>\nTrade Date: 11\/16<br \/>\nShares: 1.2 million<br \/>\nRe-Offer Range: <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><br \/>\nUnderwriter(s) : Leerink<br \/>\nCo-Manager(s): JMP Securities, Cantor Fitzgerald<br \/>\nDescription: AxoGen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair.<br \/>\nRating = <strong><a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[],"class_list":["post-3462","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3462"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3462\/revisions"}],"predecessor-version":[{"id":3464,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3462\/revisions\/3464"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3462"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}